NO962078L - Alfa-aryl - eller heteroaryl-substituerte amid-ester ACAT-inhibitorer - Google Patents
Alfa-aryl - eller heteroaryl-substituerte amid-ester ACAT-inhibitorerInfo
- Publication number
- NO962078L NO962078L NO962078A NO962078A NO962078L NO 962078 L NO962078 L NO 962078L NO 962078 A NO962078 A NO 962078A NO 962078 A NO962078 A NO 962078A NO 962078 L NO962078 L NO 962078L
- Authority
- NO
- Norway
- Prior art keywords
- heteroaryl
- aryl
- alpha
- substituted amide
- acat inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/29—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/156,225 US5420339A (en) | 1993-11-22 | 1993-11-22 | Alpha-aryl or heteroaryl-substituted amide ester ACAT inhibitors |
PCT/US1994/012299 WO1995014657A1 (en) | 1993-11-22 | 1994-10-26 | Alpha-aryl or heteroaryl-substituted amide ester acat inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
NO962078D0 NO962078D0 (no) | 1996-05-21 |
NO962078L true NO962078L (no) | 1996-05-21 |
NO317395B1 NO317395B1 (no) | 2004-10-25 |
Family
ID=22558652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19962078A NO317395B1 (no) | 1993-11-22 | 1996-05-21 | Alfa-aryl - eller heteroaryl-substituerte amid-ester ACAT-inhibitorer |
Country Status (7)
Country | Link |
---|---|
US (2) | US5420339A (no) |
EP (1) | EP0730571A1 (no) |
JP (1) | JPH09505584A (no) |
AU (1) | AU8092794A (no) |
CA (1) | CA2176042C (no) |
NO (1) | NO317395B1 (no) |
WO (1) | WO1995014657A1 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7304093B2 (en) * | 2000-10-11 | 2007-12-04 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
CN1479721A (zh) | 2000-10-11 | 2004-03-03 | ͨ��ҽ�ƹ�˾ | 用于胆固醇治疗和相关应用的亚砜和双亚砜化合物和组合物 |
US20040122091A1 (en) * | 2000-10-11 | 2004-06-24 | Esperion Therapeutics, Inc. | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
WO2002030863A2 (en) | 2000-10-11 | 2002-04-18 | Esperion Therapeutics, Inc. | Ether compounds and compositions for cholesterol management and related uses |
CA2425311C (en) | 2000-10-11 | 2011-06-14 | Esperion Therapeutics, Inc. | Ketone compounds and compositions for cholesterol management and related uses |
CN101426763A (zh) | 2000-10-11 | 2009-05-06 | 埃斯佩里安医疗公司 | 用于胆固醇治疗和相关应用的硫化物和二硫化物化合物和组合物 |
EP1341773A2 (en) * | 2000-12-07 | 2003-09-10 | Cv Therapeutics, Inc. | Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
US20040072903A1 (en) * | 2001-05-08 | 2004-04-15 | Auerbach Bruce Jeffrey | Carboxyalkylether-acat inhibitors combinations |
US20040204502A1 (en) * | 2001-10-11 | 2004-10-14 | Dasseux Jean-Louis Henri | Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
US20050020694A1 (en) * | 2001-10-11 | 2005-01-27 | Dasseux Jean-Louis Henri | Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
US20040192771A1 (en) * | 2001-10-11 | 2004-09-30 | Dasseux Jean-Louis Henri | Ether compounds and compositions for cholesterol management and related uses |
US20030236212A1 (en) * | 2002-04-10 | 2003-12-25 | Jean-Louis Dasseux | Functionalized long chain derivatives as acyl coenzyme-A mimics, compositions thereof, and methods of cholesterol management and related uses |
MXPA05007674A (es) * | 2003-01-23 | 2005-09-22 | Esperion Therapeutics Inc | Compuestos de hidroxilo y composiciones para el manejo del colesterol y usos relacionados. |
BR0318685A (pt) | 2003-12-24 | 2006-12-19 | Esperion Therapeutics Inc | compostos de cetona e composições para controle de colesterol e usos relacionados |
CN107530307A (zh) | 2015-03-13 | 2018-01-02 | 艾斯柏伦治疗公司 | 包含etc1002和依泽替米贝的固定剂量组合和制剂以及治疗心血管疾病或降低心血管疾病风险的方法 |
MA41793A (fr) | 2015-03-16 | 2018-01-23 | Esperion Therapeutics Inc | Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire |
EP3986860A1 (en) | 2019-06-21 | 2022-04-27 | Esperion Therapeutics, Inc. | Salt forms of bempedoic acid and methods for using the same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2955111A (en) * | 1957-01-28 | 1960-10-04 | Bofors Ab | Synthesis of n-alkyl-piperidine and n-alkyl-pyrrolidine-alpha-carboxylic acid amides |
AT211821B (de) * | 1959-11-26 | 1960-11-10 | Heilmittelwerke Wien Ges Mit B | Verfahren zur Herstellung Alkylaminoacetaryliden |
DD132430A1 (de) * | 1977-07-18 | 1978-09-27 | Heinz Stopsack | Verfahren zur herstellung von halbestern und halbamiden substituierter malonsaeuren |
US5123951A (en) * | 1986-03-31 | 1992-06-23 | Rhone-Poulenc Nederland B.V. | Synergistic plant growth regulator compositions |
EP0269656B1 (en) * | 1986-03-31 | 1993-12-29 | Rhone Poulenc Nederland B.V. | Novel malonic acid derivative compounds and compositions thereof for retarding plant growth |
JPH0363648A (ja) * | 1989-08-01 | 1991-03-19 | Fuji Photo Film Co Ltd | 熱現像カラー感光材料 |
US5153226A (en) * | 1989-08-31 | 1992-10-06 | Warner-Lambert Company | Acat inhibitors for treating hypocholesterolemia |
AU7745991A (en) * | 1990-04-11 | 1991-10-30 | Warner-Lambert Company | Amide ester acat inhibitors |
DE4114733A1 (de) * | 1991-05-06 | 1992-11-12 | Huels Chemische Werke Ag | Verfahren zur herstellung von substituierten malonesteraniliden und malonsaeure-monoaniliden |
US5366987A (en) * | 1991-08-22 | 1994-11-22 | Warner-Lambert Company | Isoxazolyl-substituted alkyl amide ACAT inhibitors |
-
1993
- 1993-11-22 US US08/156,225 patent/US5420339A/en not_active Expired - Lifetime
-
1994
- 1994-10-26 AU AU80927/94A patent/AU8092794A/en not_active Abandoned
- 1994-10-26 EP EP94932061A patent/EP0730571A1/en not_active Ceased
- 1994-10-26 CA CA002176042A patent/CA2176042C/en not_active Expired - Fee Related
- 1994-10-26 JP JP7515071A patent/JPH09505584A/ja active Pending
- 1994-10-26 WO PCT/US1994/012299 patent/WO1995014657A1/en not_active Application Discontinuation
-
1995
- 1995-03-06 US US08/398,704 patent/US5502198A/en not_active Expired - Fee Related
-
1996
- 1996-05-21 NO NO19962078A patent/NO317395B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
WO1995014657A1 (en) | 1995-06-01 |
US5420339A (en) | 1995-05-30 |
NO962078D0 (no) | 1996-05-21 |
EP0730571A1 (en) | 1996-09-11 |
CA2176042A1 (en) | 1995-06-01 |
JPH09505584A (ja) | 1997-06-03 |
NO317395B1 (no) | 2004-10-25 |
AU8092794A (en) | 1995-06-13 |
US5502198A (en) | 1996-03-26 |
CA2176042C (en) | 2005-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69213537D1 (de) | HLE-inhibierende heterozyklische Amide | |
NO942064D0 (no) | yminhibitorer | |
ATE217010T1 (de) | Inhibitoren der plättchenaggregation | |
NO932620D0 (no) | Amindiol-proteaseinhibitorer | |
NO981938D0 (no) | Proteaseinhibitorer | |
FI963597A0 (fi) | Isoprenyylitransferaasi-inhibiittoreita | |
NO972930D0 (no) | Fibronectin-adhesjonsinhibitorer | |
IS4771A (is) | Interlevkín-1ß umbreytiensím tálmar | |
FI972160A (fi) | Matriisimetalloproteaasi-inhibiittorit | |
NO992525L (no) | Apo-B-sekresjon/MTP-inhiberings-amider | |
FI962315A0 (fi) | Entsyymi-inhibiittorit | |
NO962078D0 (no) | Alfa-aryl - eller heteroaryl-substituerte amid-ester ACAT-inhibitorer | |
NO178386C (no) | Transduser-anordning | |
DE69429586D1 (de) | Hydrophonträger | |
DE69331709D1 (de) | Feldeffekt-emissionsvorrichtung | |
DK0645391T3 (da) | Aminobenzoesyrederivater | |
NO941151D0 (no) | Lineære adhesjonsinhibitorer | |
NO305251B1 (no) | Benzamidderivater | |
FI950486A (fi) | Amidijohdannaiset | |
NO930722D0 (no) | Imidazolylsubstituerte fenyleddiksyreamider | |
AU7745991A (en) | Amide ester acat inhibitors | |
BR9606610A (pt) | Herbicidas n-(1-etil-4-pirazolil) triazolazinasulfonamida | |
KR970004339U (ko) | 무술연습장치 | |
FI955818A0 (fi) | Uudet heterosykliset amidit | |
BR9610514A (pt) | Inibidores cicloantihelmínticos |